AOD 9604 is an unlicensed synthetic hGH peptide fragment with limited human trial data, while retatrutide is an investigational triple incretin receptor agonist
The primary 5 amino 1mq benefits include significant fat loss (particularly visceral fat), improved body composition without muscle loss, enhanced insulin sensitivity, increased cellular energy production, and support for healthy aging processes
These include combinations with other vitamins and nutrients, boosting their effectiveness
Many patients report increased energy within a day or two, with weight-loss benefits developing over several weeks of consistent use
This form of treatment has been found to be particularly beneficial when it comes to reducing nerve damage pain and symptoms in diabetes patients
But like any therapy, there are potential side effects of AOD 9604, and knowing them ahead of time can help you make an informed decision about your treatment